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Background and purpose — Osteoarthritis (OA) imposes a sub-
stantial burden on individuals and societies. We report on the 
burden of knee and hip OA in the Nordic region.  
Patients and methods — We used the fi ndings from the 2015 
Global Burden of Diseases Study to explore prevalence, years 
lived with disability (YLDs), and disability-adjusted life-years 
(DALYs) of OA in the 6 Nordic countries during 1990–2015 (pop-
ulation of about 27 million in 2015). 
Results — During 1990–2015, the number of prevalent OA 
cases increased by 43% to 1,507,587 (95% uncertainty interval 
[UI] 1,454,338–1,564,778) in the region. OA accounted for 1.3% 
(UI 1.0–1.7) of YLDs in 1990, increasing to 1.6% (UI 1.2–2.0) in 
2015. Of 315 causes studied, OA was the 15th leading cause of 
YLDs, causing 52,661 (UI 34,056–77,499) YLDs in 2015; of these 
23% were attributable to high body mass index. The highest rela-
tive importance of OA was reported for women aged 65–74 years 
(8th leading cause of YLDs in 2015). Among the top 30 leading 
causes of YLDs in the region, OA had the 5th greatest relative 
increase in total YLDs during 1990–2015. From 1990 to 2015, 
increase in age-standardized YLDs from OA in the region was 
slightly lower than increase at the global level (7.5% vs. 10.5%). 
OA was, however, responsible for a higher proportional burden of 
DALYs in the region compared with the global level.  
Interpretation — The OA burden is high and rising in the 
Nordic region. With population growth, aging, and the obesity 
epidemic, a substantial rise in the burden of OA is expected and 
should be addressed in health policies.   
■
Painful osteoarthritis (OA) of the peripheral joints is often 
associated with physical disability and deterioration in health-
related quality of life, translating into a substantial burden on 
individuals and societies (Hiligsmann and Reginster 2013, 
Cross et al. 2014, Kiadaliri et al. 2016). Although OA may 
affect all joints, the knee, hip, and hand are most commonly 
affected. OA incidence and prevalence has increased over 
recent decades and this is generally attributed to aging of the 
population and rising prevalence of obesity (Nguyen et al. 
2011, Neogi and Zhang 2013, Rahman et al. 2014, Yu et al. 
2015). In addition, occurrence of OA among younger active 
people has been reported to be increasing (Leskinen et al. 
2012, Yu 2015). 
The rising incidence and prevalence of OA implies that its 
burden will increase and impose signifi cant pressure on health-
care systems worldwide. An up-to-date and accurate estimate 
of the burden of OA and its burden in relation to other diseases 
can aid informed decision-making by health authorities. In 
addition, monitoring and comparison of the country-specifi c 
burden would provide useful insights to assess health systems’ 
performance and benchmark a country against others. How-
ever, to do so, consistent and comparable data across diseases 
and geographies over times are required. The Global Burden 
of Disease (GBD) Study (Murray and Lopez 1996) aims to 
respond to this requirement by estimating comprehensive and 
internally consistent estimates of mortality and disability from 
major diseases, injuries, and risk factors. In the latest itera-
tion of the GBD study, GBD 2015, the burden of 315 causes 
including OA has been estimated for 195 countries during 
1990–2015 (GBD 2015 DALYs and HALE Collaborators 
2016, GBD 2015 Disease and Injury Incidence and Preva-
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lence Collaborators 2016, GBD 2015 Mortality and Causes of 
Death Collaborators 2016). The GBD 2015 reported the esti-
mates for the Nordic region as a whole. In the current study, 
we aimed to explore, for the fi rst time, prevalence and dis-
ability due to OA in the Nordic region and across countries in 
the region between 1990 and 2015 using the fi ndings from the 
GBD 2015. 
Methods
The GBD 2015 estimated the burden of 315 causes of diseases 
and injuries and 79 risk factors for 195 countries, 7 super-
regions, and 21 regions. The GBD uses 3 metrics to quantify 
the burden of a disease: years of life lost (YLLs) due to prema-
ture death, years lived with disability (YLDs) for the non-fatal 
health loss, and disability-adjusted life years (DALYs) as a 
measure of total burden (fatal and non-fatal). YLLs are cal-
culated by multiplying the number of deaths from a cause in 
each age group by the reference life expectancy at the average 
age of death for those who die in that age group (GBD 2015 
Mortality and Causes of Death Collaborators 2016). YLDs for 
each age, sex, location, and calendar year are computed by 
multiplying prevalence of a given cause sequela by disability 
weights for that sequela (GBD 2015 Disease and Injury Inci-
dence and Prevalence Collaborators 2016). DALYs are calcu-
lated as the sum of YLLs and YLDs. 1 DALY is equivalent to 
1 healthy year of life lost due to a specifi c disease or injury. 
In the GBD 2015, the OA reference case defi nition was 
symptomatic OA of the hip or knee radiologically confi rmed 
as Kellgre–Lawrence grade 2–4 (GBD 2015 Disease and 
Injury Incidence and Prevalence Collaborators 2016). OA was 
assumed to be non-fatal and no mortality and no YLLs were 
estimated. For non-fatal health loss, the GBD 2013 systematic 
reviews of epidemiological measures for OA were updated 
in 2014. A list of all data points used in GBD 2015 is avail-
able from IHME Global Health Data Exchange (http://ghdx.
healthdata.org/gbd-2015/data-input-sources). 
Statistics
The detailed information on data and statistical analysis of the 
GBD 2015 study are available in the web appendix of a pre-
vious publication (GBD 2015 Disease and Injury Incidence 
and Prevalence Collaborators 2016, http://www.thelancet.
com/cms/attachment/2090344431/2075672336/mmc1.pdf). In 
short, the data from systematic reviews were assembled using 
DisMod-MR 2.1, a Bayesian meta-regression tool to estimate 
prevalence by location, age, sex, and year accounting for study 
level and predictive covariates. The sequence of estimation in 
DisMod-MR 2.1 occurs at 5 levels (called “cascade”): global, 
super-region, region, country and, where applicable, subna-
tional geographical unit. An initial run is made with all data 
points for all locations, age, sex, and time periods to get an 
initial fi t at the global level. The estimates from the global fi t 
with adjustments for fi xed effects (adjusting for study char-
acteristics and predictive covariates) and random effects by 
geography is passed on to each of 7 super-region fi ts by sex 
and year (1990, 1995, 2000, 2005, 2010, and 2015) as priors 
and confronted with data from the super-region, sex, and year 
to make an initial fi t for each super-region. For OA, the data 
from studies that reported OA based on radiographic only, 
self-reported OA with pain, reporting a physician diagnosis of 
OA, and symptomatic OA without radiographic confi rmation 
were included and adjusted as study-level covariates in the 
modelling. The mean body mass index (BMI) was included as 
a predictive covariate. Then estimates from the super-region 
are passed on similarly to 21 region fi ts by sex and year and 
in turn the region estimates determine the priors for country 
estimates, and the country estimates determine the prior being 
passed down to subnational locations, where applicable. This 
cascade allows the GBD estimates to be made for locations 
with sparse or no primary data. In addition, disease-by-disease 
value priors may be set. In the case of OA, a prior value of no 
incidence and prevalence before the age of 30, zero remission, 
and no excess mortality were assumed. Based on the severity of 
OA, 3 sequelae (mild, moderate, and severe OA) were consid-
ered. Severity was classifi ed according to the Western Ontario 
and McMaster Universities Arthritis Index (WOMAC) and the 
lay description of these was used to elicit disability weights. 
A random effects meta-analysis model based on the data from 
4 studies from 3 regions was used to determine the proportion 
of people within each of the OA severity levels (based on fre-
quentist methods). All measures were age-standardized using 
the GBD world population age standard. 
For each measure, 95% uncertainty intervals (UI) were 
calculated by taking the 2.5 and 97.5 centile values of 1,000 
draws of the posterior distribution of that measure. It should 
be noted that as YLLs for OA was assumed to be zero, the 
YLDs is equal to DALYs. 
We obtained the estimates of the GBD 2015 on the burden 
of OA for the Nordic region and the 6 countries in the 
region (Denmark, Finland, Greenland, Iceland, Norway, and 
Sweden) for 1990–2015 at 5-year increments (1990, 1995, 
2000, 2005, 2010, and 2015) from the Institute for Health 
Metrics and Evaluation interactive visualization tools (http://
vizhub.healthdata.org/gbd-compare). The region had a popu-
lation of around 23 million in 1990 and 27 million in 2015. We 
reported the burden of OA attributable to high BMI (≥ 22.5) 
(GBD 2015 Risk Factors Collaborators 2016). We also com-
pared the observed YLDs of OA with those expected based on 
the socio-demographic index (SDI). The SDI was constructed 
in the GBD 2015 for each location-year as a measure of over-
all development. It is based on the geometric mean of income 
per capita, average years of schooling among people aged 
15 years or older, and total fertility rate (GBD 2015 DALYs 
and HALE Collaborators 2016). In the Nordic region in 2015 
the SDI values were as follow: 0.76 for Greenland, 0.89 for 
Sweden, 0.89 for Finland, 0.91 for Denmark, and 0.94 for 
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Norway. We also decomposed the changes in total YLDs from 
OA between 1990 and 2015 into population growth, aging, 
and change in age- and sex-specifi c YLD rates of OA. 
Ethics, funding, and potential confl icts of interest
Ethics approval not applicable; data are publicly available. 
We would like to acknowledge support from the Swedish 
Research Council, Crafoord Foundation, Greta and Kocks 
Foundation, Österlunds Foundation, the Faculty of Medicine 
Lund University, Governmental Funding of Clinical Research 
within National Health Service (ALF) and Region Skåne. No 
confl icts of interest declared.
Results
Prevalence 
The number of prevalent OA cases increased from 
1,051,897 (UI 1,017,093–1,089,896) in 1990 to 1,507,587 
(UI 1,454,338–1,564,778) in 2015 in the Nordic region (an 
increase of 43% [UI 41–45]). The age-standardized preva-
lence of OA for women in the region was comparable to the 
19,987–45,631) in women; and by 53% (UI 49–55) to 21,687 
(UI 14,064–32,040) in men in the Nordic region. In both sexes, 
the increases in total YLDs from 1990–2015 in the region were 
smaller than the global rate of increase (Figure S1, Supple-
mentary data). In the Nordic region, OA contributed to 1.33% 
(UI 1.00–1.67) of total YLDs in 1990 and this increased to 
1.61% (UI 1.22–2.01) in 2015 (ranging from 1.37% [UI 1.03 
to 1.72] in Greenland to 1.85% [UI 1.40–2.31] in Denmark, 
Figure 2). Of 315 causes studied, OA was ranked as the 15th 
leading cause of total YLDs in the region in 2015 (Figure 3). 
In addition, OA was among 10 leading causes of YLDs in 
those aged 55–74 years in 2015 (Figure S2, Supplementary 
data). While overall OA had a higher relative importance in 
women (14th leading cause of YLDs) than men (20th leading 
cause of YLDs), in those aged 30–50 years the opposite was 
observed. Among the top 30 leading causes of YLDs in the 
region, OA had the 5th greatest relative increase in total YLDs 
between 1990 and 2015 (Table 2). 
In both sexes, the highest and lowest age-standardized YLD 
rates of OA were seen in Greenland and Sweden, respectively 
(Figure S3, Supplementary data). The ratio of age-standard-
ized YLDs rate in the Nordic region to the global level was 
Table 1. Age-standardized prevalence (%) of osteoarthritis in the countries of the Nordic region and the world 
  Women Percent change Men Percent change
Location 1990 2015  1990–2015 1990 2015 1990–2015
Global 3.8 (3.7–3.9) 4.1 (3.9–4.2) 6.6 (5.6–7.6) 2.6 (2.6–2.7) 2.8 (2.8–2.9) 7.6 (6.5–8.5)
Nordic region 3.7 (3.6–3.9) 4.0 (3.9–4.2) 8.4 (6.6–10.2) 2.9 (2.8–3.1) 3.2 (3.1–3.3) 8.1 (6.3–9.8)
 Denmark 4.3 (4.1–4.5) 4.6 (4.4–4.8) 7.2 (3.8–10.9) 3.5 (3.3–3.6) 3.7 (3.6–3.9) 8.1 (4.6–11.8)
 Finland 3.9 (3.7–4.0) 4.1 (3.9–4.2) 4.8 (1.0–8.7) 3.0 (2.9–3.1) 3.2 (3.1–3.3) 6.4 (2.7–10.3)
 Greenland 4.4 (4.2–4.6) 4.8 (4.6–5.0) 8.1 (4.7–12.0) 3.6 (3.4–3.7) 3.9 (3.7–4.0) 7.9 (4.5–11.2)
 Iceland 4.1 (3.9–4.3) 4.4 (4.2–4.7) 8.2 (3.9–13.0) 3.2 (3.1–3.4) 3.5 (3.3–3.7) 9.1 (4.9–13.6)
 Norway 3.6 (3.5–3.8) 3.9 (3.7–4.1) 7.4 (3.4–11.8) 2.9 (2.8–3.1) 3.2 (3.0–3.3) 8.0 (3.8–11.7)
 Sweden 3.4 (3.2–3.5) 3.8 (3.6–3.9) 11.9 (8.3–15.8) 2.6 (2.5–2.7) 2.8 (2.7–3.0) 8.7 (5.1–11.9)
Values in parentheses show 95% uncertainty interval.  
Figure 1. Age- and sex-specifi c prevalence (%) of osteoarthritis in the Nordic region and the 
world, 2015.
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global level, even though it was estimated to 
be higher in Denmark, Greenland, and Ice-
land and lower in Sweden compared with 
the global level (Table 1). Among men, the 
age-standardized prevalence of OA in all 
Nordic countries but Sweden was higher 
than the global average. Between 1990 and 
2015, the age-standardized prevalence of OA 
increased by 7.5% (UI 6.1–8.9) in the region, 
which was slightly higher than the observed 
increase at the global level. In both sexes, the 
highest prevalence was observed in people 
75–79 years old (Figure 1).
YLDs
Between 1990 and 2015, total YLDs of OA 
increased by 38% (UI 35–40) to 30,974 (UI 
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0.65 in women and 0.73 in men. Between 1990 and 2015, the 
age-standardized YLDs rate of OA rose by 7.5% (UI 6.0–9.1) 
in the region, statistically signifi cantly lower than the observed 
increase at the global level (10.5%, UI 9.1–12.0, Figure S1, 
Supplementary data). Across the Nordic countries, the largest 
and smallest increases in age-standardized YLD rates of OA 
were reported for women in Sweden and Finland, respectively. 
DALYs
Between 1990 and 2015, the burden of OA as a proportion of 
total DALYs increased from 0.69% (UI 0.49–0.93) to 0.97% 
(UI 0.70–1.30) in women and from 0.38% (UI 0.26–0.52) to 
0.63% (UI 0.45–0.85) in men in the Nordic region (Figure 2). 
While globally OA was ranked as 35th (66th) leading cause 
of total DALYs in women (men) in 2015, it had a higher rela-
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Figure 2. Burden of osteoarthritis as a proportion of total years lived with disability (YLDs) and disability-adjusted life years (DALYs) 1990–2015, 
by sex and location.
Figure 3. The rank of osteoarthritis among 315 causes in terms of total years lived with disability 
(YLDs) and disability-adjusted life years (DALYs) in 1990 and 2015, by sex and location (lower 
number indicates higher relative importance).
 YLDs DALYs
  Women Men Both Women Men Both
 Location 1990  2015 1990  2015 1990  2015 1990  2015 1990  2015 1990  2015
Global 15 12 27 17 16 13 60 35 101 66 81 42
Nordic region 17 14 25 20 18 15 33 26 59 39 41 29
 Denmark 16 12 22 15 17 13 32 24 51 34 39 27
 Finland 18 15 27 18 23 15 35 27 63 40 46 30
 Greenland 28 17 33 20 32 18 71 42 87 58 84 53
 Iceland 20 14 29 17 21 13 36 21 55 38 43 28
 Norway 17 14 26 22 17 15 35 27 56 39 45 32
 Sweden 16 14 26 22 20 16 33 26 56 43 44 31
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In 2015, the women-to-men age-stan-
dardized YLDs rate ratio was 1.27 in 
the region (ranging from 1.22 in Den-
mark to 1.32 in Sweden), which was 
slightly lower than the global level 
(1.43). 
Among women, the observed age-
standardized YLD rates of OA were 
lower than expected on the basis of 
SDI alone in all Nordic countries, but 
among men this was the case only 
in Finland, Greenland, and Sweden 
in 2015 (Figure S4, Supplementary 
data). While the highest YLD rates 
were observed for people aged 75–79 
years in both sexes, those women 
aged 80+ years and men aged 65–69 
years had the highest number of YLDs 
(Figure 4). YLD rates were higher in 
women compared with men in all age 
groups except those aged 30–39 years. 
In the Nordic region in 2015, 23.7% 
and 22.4% of total YLDs of OA were 
attributable to high BMI in women 
and men, respectively, higher than the 
global average (Figure S5, Supplemen-
tary data). The decomposition analysis 
suggested that in all Nordic countries 
but Sweden and Norway, population 
aging made the highest contribution 
to the rise in total YLDs from 1990 to 
2015 (Table 3, Supplementary data). 
Figure 4. Total and age-specifi c rates of years lived with disability (YLDs) from osteoarthritis in the 
Nordic region in 2015, by sex and age groups.
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tive importance in the region (ranked as 26th and 39th leading 
cause of total DALYs in women and men, respectively (Figure 
3). 
Discussion 
This report is, to our knowledge, the fi rst comparative inves-
tigation of the OA burden in the Nordic region. The burden 
of OA consistently rose in the region from 1990 through 
2015, mainly due to population aging. The burden peaked in 
the 75–79 age group and was higher in women than in men. 
In addition, OA was among the 10 leading causes of YLDs 
in those aged 55–74 years in 2015. While the prevalence of 
OA in the region was comparable to the global level, the age-
standardized estimate of OA burden was lower than the global 
average. Moreover, the region experienced slightly lower 
increases in OA burden than the global average between 1990 
and 2015. On the other hand, while OA was globally ranked 
as 42nd leading cause of DALYs, it had higher relative impor-
tance in the Nordic region (29th leading cause). Across the 
countries in the region, Greenland had the highest age-stan-
dardized OA burden and the highest proportion of OA burden 
from total YLDs was seen in Denmark. 
There were persistent increases in prevalence and burden of 
OA across all Nordic countries from 1990 through 2015. The 
aging population alongside the limited effect of treatments for 
OA are possible explanations for this increasing trend. Fur-
thermore, marked increases in overweight and obesity in the 
region (Asgeirsdottir and Gerdtham 2016) could explain part 
of the rise in OA burden. However, as a recent study noted 
(Wallace et al. 2017), increases in longevity and obesity cannot 
fully explain recent increases in OA burden and recent envi-
ronmental changes (e.g., physical inactivity and high intake of 
refi ned carbohydrates) might have played an important role. 
Moreover, the role of advances in diagnosis and medicaliza-
tion should not be ruled out as more people are recognizing 
OA as a treatable condition, not just a given for getting old. 
The expected future increases in life expectancy and preva-
lence of overweight and obesity imply that the OA burden will 
continue to rise in the coming decades. A recent study reported 
rises in incidence of knee arthroplasty across Nordic countries 
between 1997 and 2012 (Niemelainen et al. 2017). More-
over, the rate of hospital admissions due to knee and hip OA 
Table 2. The burden of OA in comparison with 30 leading causes of years lived with disability (YLDs) for both sexes com-
bined in the Nordic region in 2015
   
    Percent change1990–2015 in
    total crude age-standardized
Rank  Cause  Total YLDs (95% UI), 2015 YLDs YLD rates YLD rates
1 Low back pain 341,720 (243,165–471,373) 16.5 1.6 –2.4
2 Neck pain  257,221 (173,423–347,621) 24.1 8.3 1.5
3 Major depressive disorder 171,717 (115,456–234,977) 11.5 –2.7 –3.0
4 Age-related and other hearing loss 148,248 (101,265–208,190) 37.0 19.6 4.4
5 Diabetes mellitus  138,677 (95,904–190,884) 56.1 36.2 19.6
6 Migraine  132,779 (81,995–196,494) 11.6 –2.6 –0.2
7 Anxiety disorders 114,250 (78,464–154,855) 11.8 –2.4 –1.1
8 Other musculoskeletal disorders 104,139 (69,148–144,842) 40.4 22.5 12.9
9 Falls  92,541 (63,146–129,745) –3.5 –15.8 –25.9
10 Iron-defi ciency anemia 82,713 (55,250–120,348) 24.2 8.4 13.1
11 Asthma  73,429 (47,637–102,761) –7.6 –19.4 –18.1
12 Alzheimer’s disease and other dementias 66,549 (47,170–88,334) 39.6 21.8 0.9
13 Edentulism and severe tooth loss 61,886 (41,423–86,253) 30.8 14.2 0.5
14 Chronic obstructive pulmonary disease 55,530 (46,435–65,762) 25.0 9.1 –3.9
15 Osteoarthritis  52,661 (34,056–77,499) 43.3 25.1 7.5
16 Schizophrenia 46,913 (34,275–58,739) 17.4 2.5 –0.8
17 Dysthymia 42,564 (28,457–61,162) 18.2 3.1 –0.3
18 Bipolar disorder 39,793 (24,723–58,761) 12.2 –2.1 0.9
19 Dermatitis  39,510 (27,057–54,714) 12.5 –1.9 0.0
20 Other mental and substance use disorders 38,861 (27,055–52,365) 17.0 2.1 0.6
21 Alcohol use disorders 38,585 (25,998–54,459) 3.1 –10.1 –10.5
22 Medication overuse headache 38,539 (25,260–54,435) 16.3 1.5 –1.7
23 Benign prostatic hyperplasia 37,653 (24,423–53,434) 45.6 27.0 6.9
24 Rheumatoid arthritis 37,311 (26,047–49,975) 15.6 0.9 –9.9
25 Psoriasis  36,829 (25,740–49,858) 20.2 4.9 1.2
26 Atrial fi brillation and fl utter 36,593 (24,776–49,774) 62.5 41.8 21.4
27 Other sense organ diseases 35,211 (22,070–51,023) 29.0 12.5 2.2
28 Ischemic heart disease 31,912 (21,923–43,427) –1.7 –14.2 –26.5
29 Other unintentional injuries 30,357 (19,917–43,616) –33.4 –41.9 –48.2
30 Other congenital birth defects 29,647 (12,960–72,466) 99.0 73.6 77.2
UI = uncertainty interval. 
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increased by 50% and 32% between 1998 and 2015 in Sweden 
(http://www.socialstyrelsen.se). Furthermore, healthcare con-
sultation for OA and primary knee arthroplasty are projected 
to rise in coming decades in Sweden (Turkiewicz et al. 2014, 
Nemes et al. 2015). These rising trends highlight the need to 
incorporate prevention and treatment of OA and sports-related 
injuries as a priority in health policies in the region. At the 
population level, raising public awareness about the impor-
tance of a healthy lifestyle (e.g., maintain physical fi tness and 
an ideal weight, follow a balanced diet), improving occupa-
tional safety and ergonomics, and promoting public awareness 
of OA should be part of any preventive initiative (Mody and 
Brooks 2012, Woolf et al. 2012, Bruyere et al. 2014, Briggs et 
al. 2016, Moradi-Lakeh et al. 2017). At patient level, inform-
ing patients about the nature of the disease and treatment goals 
and importance of self-management, providing lifestyle rec-
ommendations (exercise and weight loss), and implementation 
of integrated models of patient-centered multidisciplinary care 
have been suggested in order to address the rising burden of 
OA (Mody and Brooks 2012, Woolf et al. 2012, Bruyere et al. 
2014, Briggs et al. 2016). Along these lines, OA prevention and 
management programs aiming to offer adequate information 
and exercise to people with knee or hip OA have been initiated 
in Sweden (Better management of patients with OsteoArthri-
tis, https://boa.registercentrum.se/), Denmark (Good Life with 
osteoArthritis in Denmark, https://www.glaid.dk/) and Norway 
(ActiveOA—Active living with osteoarthritis, http://aktivmed-
artrose.no/) and establishing similar programs in other Nordic 
countries is highly recommended. 
The magnitude and trend of OA burden varied by sex and 
country. Incidence, prevalence, and severity of OA is higher 
in women compared with men (Srikanth et al. 2005, Neogi 
and Zhang 2013), and any preventive and therapeutic inter-
vention should consider this sex difference. In addition, while 
the changes in age-standardized YLD rates of OA were com-
parable between sexes, men observed greater increases in 
total YLDs than women did over the observation period. This 
might be partly due to a higher gain in life expectancy in men 
compared with women over the study period in the Nordic 
region (life expectancy at birth increased by 6.0 years in men 
and 4.2 years in women from 1990 through 2015 (GBD 2015 
Mortality and Causes of Death Collaborators 2016)). Differ-
ences in population genetic predisposition and lifestyle, in 
epidemiologic and clinical profi le of OA, in prevalence of 
OA risk factors, and in the healthcare system might partially 
explain variation in OA burden across the Nordic countries 
(Croft 1996, Petersson and Jacobsson 2002). Further investi-
gations are required to explore the observed variations in the 
magnitude and secular trends of OA burden in the region. 
In addition to the general limitations of the GBD 2015, which 
have been acknowledged (GBD 2015 DALYs and HALE Col-
laborators 2016, GBD 2015 Disease and Injury Incidence 
and Prevalence Collaborators 2016, GBD 2015 Risk Factors 
Collaborators 2016), several OA-specifi c limitations should 
be mentioned. The reference case defi nition based on Kell-
gren–Lawrence grades 2–4 is a conservative defi nition of OA 
(Cross et al. 2014) excluding a substantial part of early-stage 
OA patients from the estimates. The distribution of people 
across the OA severity levels was determined mainly using 
the data from high-income regions with no adjustment for 
potential changes over time. In addition, the brief lay descrip-
tions used to elicit disability weights were mainly focused on 
major functional consequences and symptoms that could not 
fully capture the impact of OA on other aspects of health and 
well-being. The burden of OA was limited to knee and hip OA 
and other sites were not included. All these limitations likely 
led to underestimation of the true OA burden in this study. 
Nevertheless, these results provide an up-to-date comparative 
assessment of OA burden in the Nordic region of importance 
to policy-makers and health professionals.  
Summary
The burden of OA is high and rising in the Nordic region. 
While among women prevalence of OA was comparable 
to the global average, men had a higher prevalence than 
the global level. There were persistent increases in the 
age-standardized rates of OA burden with time. Further-
more, OA was responsible for a higher proportional burden 
of total DALYs in the Nordic region compared with the 
global level. Among the top 30 leading causes of YLDs 
in the region, OA had the 5th greatest relative increase in 
total YLDs from 1990 to 2015. In all Nordic countries but 
Denmark the observed OA burden was lower than expected 
based on sociodemographic status, but worryingly this 
gap between the observed and expected number of YLDs 
is closing. Current trends in population growth, aging, and 
prevalence of overweight and obesity will lead to a further 
increase in OA burden in coming years and call for incor-
porating OA prevention and treatment as a priority in health 
policies in the Nordic region. 
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